JULY 9, 2020 — Fueling transformative research through collaboration, the San Antonio Partnership for Precision Therapeutics has announced the funding of three more collaborative COVID-19 research efforts in San Antonio. SAPPT has awarded more than $600,000 to fund these projects, following the funding of a SARS CoV-2 vaccine project announced in April of this year.
Launched in 2019 to accelerate the process of getting therapies and pharmaceuticals from basic research to people in need, the SAPPT was created by four leading San Antonio research organizations: Southwest Research Institute, Texas Biomedical Research Institute, The University of Texas Health Science Center at San Antonio, and The University of Texas at San Antonio. SAPPT uses precision medicine principles to maximize therapy effectiveness and seeks to provide solutions for diverse populations not unlike the unparalleled population diversity of the San Antonio region.
This round of funding is made possible through USAA’s commitment of $1 million to organizations combatting COVID-19, including SAPPT. With the formal partnership and collaborative mechanism in place, SAPPT organized and issued a call for proposals and within weeks had selected three projects to fund, each a collaborative effort among the four research institutions with promising early milestones. The San Antonio Area Foundation also committed close to $100,000 to SAPPT to accelerate their collaborative efforts to understand, treat and prevent COVID-19.
Diako Ebrahimi and his team at Texas Biomed are studying the role of the protein FURIN in COVID-19 and how it is potentially impacting individual responses to the virus. The team is initially studying its role as a link to greater mortality rates for individuals with underlying cardiovascular conditions. This research team is working to identify interactions FURIN has with the virus that could impact mortality rates, with the ultimate goals of being able to develop inhibitors to stop this interaction. Supporting research teams are led by Jonathan Bohmann, SwRI; Zhenming Xu and Dean L. Kellogg Jr., UT Health San Antonio, and Stanton McHardy and Doug Frantz, UTSA.
“While we’re talking about COVID-19 specifically in this research, the implications are much farther reaching,” said Larry Schlesinger, president and CEO of Texas Biomed. “We can use what we learn here and apply that knowledge to combatting the next novel coronavirus, HIV and other infectious diseases. This study has a true precision therapy goal, since it aims to understand why certain individuals have greater severity of disease and why specific underlying conditions affect outcomes.”
The research team, led by Dmitri Ivanov with UT Health San Antonio, is working to identify how COVID-19 evades our innate immune system and blocks our body’s ability to quickly detect the virus and mount an antiviral response. The goal is to identify antiviral compounds either among existing FDA-approved treatments or in vast libraries of drug-like molecules that could effectively combat the ability of the virus to evade our immune defenses. This work would not only broaden our understanding of how viruses interact with human immune systems, it could also accelerate the process of identifying new antiviral treatments in the future. Supporting Ivanov are teams from the four research institutions including Jonathan Bohmann, SwRI; Luis Martinez-Sobrido, Texas Biomed; and Stanton McHardy, UTSA.
“When San Antonio’s leading researchers come together, great things happen,” said William Henrich, president of UT Health San Antonio. “Among our four research institutions, we have the talented people needed to drive innovation through collaboration.”
The third of the funded projects is led by Yogesh Gupta of UT Health San Antonio. Gupta and his team are studying how the novel coronavirus evades the human immune system by mimicking the host RNA and growing inside the body. By understanding this process, the goal is to develop novel inhibitors that can block specific pathways that permit the virus to replicate inside the host cell. The innovative drug discovery platform will pave the way in developing a new class of drugs to fight COVID-19, while also preparing to combat emerging coronaviruses in the future. The supporting team assembled from the four research institutions includes Jonathan Bohmann and Hakima Ibaroudene, SwRI; Luis Martinez-Sobrido, Texas Biomed; and Stanton McHardy and Doug Frantz, UTSA.
“This virus causes disease with varied effects, from asymptomatic and mild symptoms for some infected persons to more severe symptoms that require hospitalization and intubation in others. And of course, in some unfortunate cases, the disease may lead to the patient’s death. In addition, COVID-19 seems to impact some parts of our community harder than others. Part of the SAPPT role is to work to find ways to prevent and treat this disease for all of our community,” said Adam Hamilton, president and CEO of SwRI.
“These three additional projects support a strong foundation of transformative COVID-19 research happening in San Antonio. From better understanding the virus and applying custom therapies to developing drug treatments and vaccines, our partnership is in the unique position to make a real difference in the global impact of this pandemic,” said Taylor Eighmy, president of UTSA.
All three projects have begun work and will report initial milestones to SAPPT as early as August.
Interested in wellbeing programs, events and resources? Every Wednesday at noon you can stop by virtually and ask any questions you may have about Student Health Services, Counseling and Mental Health Services, and the PEACE office.Virtual Event
Learn more about Omada Health, a free healthy living program available to eligible UTSELECT members. This will be a live webinar in honor of National Nutrition Month (March) and Diabetes Alert Day (March 23). Get your questions answered and find out if Omada is right for youVirtual Event
Join our Health Education team and our Relationship Advocate as we discuss all things Sexual Health, STIs, Healthy Relationships, and more! This is your chance to learn what wasn't taught in High School! You can even submit questions anonymously and we'll answer them.Virtual Event
Session for social scientists on how to identify and understand which programs within NSF and NIH fund social sciences, what reviewers are typically looking for, and common mistakes to avoid. The presenter will also cover how to identify private foundations that may be interested in funding your social science research.Virtual Event
Join our Health Educators as we go over a very brief and basic presentation over proper nutrition, reading food labels, and portion sizes.Virtual Event
Open to members of the LGBTQ in all stages of identity formation from questioning to integration who seek a safe place to discuss issues.Virtual Event
General Assembly is a time when all members and officers of SGA come together to discuss important issues regarding UTSA and finding solutions through legislation or initiatives. Important updates are regularly given by SGA officers, UTSA administrators, or special guests. Our meetings are open to the public and are held on a weekly basis.Virtual Event
The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property - for Texas, the nation and the world.
To be a premier public research university, providing access to educational excellence and preparing citizen leaders for the global environment.
We encourage an environment of dialogue and discovery, where integrity, excellence, inclusiveness, respect, collaboration and innovation are fostered.
UTSA is a proud Hispanic Serving Institution (HSI) as designated by the U.S. Department of Education.
The University of Texas at San Antonio, a Hispanic Serving Institution situated in a global city that has been a crossroads of peoples and cultures for centuries, values diversity and inclusion in all aspects of university life. As an institution expressly founded to advance the education of Mexican Americans and other underserved communities, our university is committed to ending generations of discrimination and inequity. UTSA, a premier public research university, fosters academic excellence through a community of dialogue, discovery and innovation that embraces the uniqueness of each voice.